Allogeneic Stem Cell-Based Platforms to Potentiate and Deliver Oncolytic Virus Therapies

Time: 9:30 am
day: Day Two

Details:

  • Shortcomings of unprotected oncolytic virus therapies
  • Advantages of Calidi’s stem cell-based platforms for potentiation of oncolytic virotherapies – preclinical data
  • Calidi’s clinical programs

Speakers: